Management of Prolonged Pregnancy

File Name		Description			Software	Version	File	Size
__________________________________________________________________________________________________________
01front.doc		Microsoft Word® Document	MS Word®	2002	57KB	10 pages
Contents: Title Page, Preface, Structured Abstract, Table of Contents

02summ.doc		Microsoft Word® Document	MS Word®	2002	67KB	10 pages
Contents: Summary: Overview, Reporting the Evidence, Methodology, Findings, Future Research

03chap1.doc		Microsoft Word® Document	MS Word®	2002	108KB	14 pages
Contents: Chapter 1. Introduction: Background; Normal Variation versus Pathology; 
Errors in Dating; Burden of Illness; Risks Associated with Prolonged Pregnancy; 
Scope and Purpose; Patient Populations; Practice Settings; Target Audiences

04tbl1.doc		Microsoft Word® Document	MS Word®	2002	35KB	1 page
Contents: Table 1. Observed relationship between gestational age and stillbirth risk

05chap2.doc		Microsoft Word® Document	MS Word®	2002	78KB	8 pages
Contents: Chapter 2. Methodology: Topic Assessment and Refinement; Literature Search 
and Selection; Data Abstraction; Quality Scoring; Quality Control Procedures; 
Supplemental Data Sources; Supplemental Analyses

06fig1.doc		Microsoft Word® Document	MS Word®	2002	82KB	1 page
Contents: Figure 1. Diagrammatic representation of causal pathway

07tbl2.doc		Microsoft Word® Document	MS Word®	2002	21KB	1 page
Contents: Table 2. Original search strategy

08tbl3.doc		Microsoft Word® Document	MS Word®	2002	21KB	1 page
Contents: Table 3. Additional search terms suggested by advisory panel

09tbl4.doc		Microsoft Word® Document	MS Word®	2002	29KB	1 page
Contents: Table 4. Number of articles identified, by literature database

10tbl5.doc		Microsoft Word® Document	MS Word®	2002	55KB	1 page
Contents: Table 5. Results of abstract screening and full-text article reviews

11chap3.doc		Microsoft Word® Document	MS Word®	2002	399KB	42 pages
Contents: Chapter 3. Results: Question 1. Test Characteristics and Costs of Measures; 
Question 2. Planned Induction vs. Expectant Management; Question 3. Benefits, Risks and 
Costs of Interventions; Question 4. Differences in Epidemiology and Outcomes 
According to Race, SES, and Age

12tbl6&7.doc		Microsoft Word® Document	MS Word®	2002	46KB	1 page
Contents: Table 6. Number of articles providing sensitivity and specificity data, 
by test studied; Table 7. Outcomes reported in association with test results in 2-by-2 tables

13tbl8.doc		Microsoft Word® Document	MS Word®	2002	141KB	6 pages
Contents: Table 8. Nonstress test performance characteristics

14tbl9.doc		Microsoft Word® Document	MS Word®	2002	38KB	1 page
Contents: Table 9. Specific fetal heart rate abnormalities on antepartum testing

15tbl10.doc		Microsoft Word® Document	MS Word®	2002	29KB	1 page
Contents: Table 10. Test performance characteristics of contraction stress testing 
using oxytocin

16tbl11.doc		Microsoft Word® Document	MS Word®	2002	141KB	4 pages
Contents: Table 11. Amniotic fluid volume measurement for oligohydramnios 
based on various criteria

17tbl12.doc		Microsoft Word® Document	MS Word®	2002	42KB	2 pages
Contents: Table 12. Components of biophysical profile scores in included studies

18tbl13.doc		Microsoft Word® Document	MS Word®	2002	44KB	1 page
Table 13. Simple biophysical profile test performance characteristics

19tbl14.doc		Microsoft Word® Document	MS Word®	2002	38KB	1 page
Contents: Table 14. Complex biophysical profile test performance characteristics

20tbl15.doc		Microsoft Word® Document	MS Word®	2002	39KB	1 page
Contents: Table 15. Doppler examination of umbilical artery flow test 
performance characteristics

21tbl16.doc		Microsoft Word® Document	MS Word®	2002	46KB	1 page
Contents: Table 16. Accuracy of antenatal fetal weight estimation for predicting macrosomia

22tbl17.doc		Microsoft Word® Document	MS Word®	2002	28KB	1 page
Contents: Table 17. Components of the Bishop score

23t18&19.doc		Microsoft Word® Document	MS Word®	2002	36KB	1 page
Contents: Table 18. Bishop score test performance characteristics; Table 19. Fetal fibronectin 
test performance characteristics

24tbl20.doc		Microsoft Word® Document	MS Word®	2002	36KB	1 page
Contents: Table 20. Perinatal mortality (excluding deaths due to congenital abnormalities)

25tbl21.doc		Microsoft Word® Document	MS Word®	2002	35KB	1 page
Contents: Table 21. Overall cesarean section rates

26t22&23.doc		Microsoft Word® Document	MS Word®	2002	47KB	1 page
Contents: Table 22. Summary odds ratios for cesarean section in randomized trials of 
elective induction versus expectant management; Table 23. Mean maternal length of stay, 
induction versus expectant management

27tbl24.doc		Microsoft Word® Document	MS Word®	2002	74KB	3 pages
Contents: Table 24. Perinatal outcomes, induction versus monitoring

28tbl25.doc		Microsoft Word® Document	MS Word®	2002	70KB	3 pages
Contents: Table 25. Maternal outcomes, induction versus monitoring

29tbl26.doc		Microsoft Word® Document	MS Word®	2002	73KB	3 pages
Contents: Table 26. Resource use, induction versus monitoring

30tbl27.doc		Microsoft Word® Document	MS Word®	2002	45KB	1 page
Contents: Table 27. Sweeping of the membranes to promote labor and reduce need for induction

31tbl28.doc		Microsoft Word® Document	MS Word®	2002	44KB	1 page
Contents: Table 28. Misoprostol tablets versus PGE2 gel

32tbl29.doc		Microsoft Word® Document	MS Word®	2002	31KB	1 page
Contents: Table 29. Births by race of mother (1998 birth certificate data)

33tbl30.doc		Microsoft Word® Document	MS Word®	2002	33KB	1 page
Contents: Table 30. Percent distribution of selected secondary discharge diagnoses, by race, 
in patients with discharge diagnosis of "prolonged pregnancy"

34tbl31.doc		Microsoft Word® Document	MS Word®	2002	33KB	1 page
Contents: Table 31. Percent distribution of selected secondary discharge diagnoses, by payer, 
in patients with discharge diagnosis of "prolonged pregnancy"

35chap4.doc		Microsoft Word® Document	MS Word®	2002	41KB	5 pages
Contents: Chapter 4. Conclusions: Summary of Findings; Research Implications; 
Limitations of the Current Literature; Limitations of the Report; Suggested Strategies 
for Using this Report

36chap5.doc		Microsoft Word® Document	MS Word®	2002	36KB	4 pages
Contents: Chapter 5. Future Research: Estimation of Risks Associated with Prolonged Gestation; 
Testing Methods; Planned Induction versus Expectant Management; Interventions for Induction; 
Special Populations

37refs.doc		Microsoft Word® Document	MS Word®	2002	81KB	9 pages
Contents: References

38abbrs.doc		Microsoft Word® Document	MS Word®	2002	26KB	2 pages
Contents: Abbreviations Used in the Report and Evidence Tables

39etbl1.doc		Microsoft Word® Document	MS Word®	2002	852KB	86 pages
Contents: Evidence Table 1. Studies Relevant to Question 1

40etbl2.doc		Microsoft Word® Document	MS Word®	2002	306KB	27 pages
Contents: Evidence Table 2. Studies Relevant to Question 2

41etbl3a.doc		Microsoft Word® Document	MS Word®	2002	628KB	59 pages
Contents: Evidence Table 3. Studies relevant to Question 3

42etbl3b.doc		Microsoft Word® Document	MS Word®	2002	531KB	51 pages
Contents: Evidence Table 3. Studies relevant to Question 3 (continued)

43biblio.doc		Microsoft Word® Document	MS Word®	2002	208KB	29 pages
Contents: Bibliography

44app1.doc		Microsoft Word® Document	MS Word®	2002	150KB	10 pages
Contents: Appendix 1. Data Abstraction Form

45app2.doc		Microsoft Word® Document	MS Word®	2002	53KB	2 pages
Contents: Appendix 2. Evidence Table Template
__________________________________________________________________________________________________________

AHRQ Publication No. 02-E018
Current as of May 2002